IP Library Granted Patent US 12,102,083
Granted Patent B2
US 12,102,083 · App. 17/228,058 · Granted Oct 1, 2024

Freezing and archiving cells on a microfluidic device

Inventors: Mark P. White (San Francisco, CA); Kevin T. Chapman (Santa Monica, CA); Andrew W. McFarland (Berkeley, CA); Eric D. Hobbs (Livermore, CA); Randall D. Lowe, Jr. (Emeryville, CA)
Assignee: BRUKER CELLULAR ANALYSIS, INC.
A01N1/0284A01N1/0221A01N1/0263B01L3/502715B01L3/502761C12M47/04B01L2200/0668B01L2300/021B01L2300/024B01L2300/0864B01L2300/16B01L2300/163B01L2300/18B01L2300/1894
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,102,083
App. No.
17/228,058
Granted
Oct 1, 2024
Kind
B2
Abstract

A method of processing and storing biological cells includes introducing a flowable medium into a microfluidic device, the flowable medium including biological cells; sequestering one or more biological cells from the flowable medium in one or more isolation regions of the microfluidic device; and freezing the microfluidic device including the one or more biological cells sequestered therein.

Claims (24)

1. A method of processing and storing biological cells, comprising:

introducing a flowable medium including biological cells into a microfluidic device, the microfluidic device comprising a base comprising an electrode activation substrate with a microfluidic circuit structure disposed thereupon, the microfluidic circuit structure comprising a flow region and one or more isolation chambers, wherein each of the isolation chambers comprises an isolation region and a connection region, the connection region having a proximal opening into the flow region and a distal opening into the respective isolation region, and further wherein the isolation region is an unswept region having a single opening into the respective connection region, the microfluidic device further comprising a cover;

sequestering one or more biological cells from the flowable medium in one or more isolation regions of the microfluidic device; and

freezing the microfluidic device including the one or more biological cells sequestered therein.

2. The method of claim 1 , wherein each isolation region has a volume in a range between 1.5×10 5 cubic microns to 1.5×10 6 cubic microns.

3. The method of claim 1 , wherein a single biological cell is sequestered in each of a plurality of the isolation regions.

4. The method of claim 1 , wherein each isolation region is configured to sequester 10 cells to 50 cells.

5. The method of claim 1 , wherein a width W con of the connection region of each isolation chamber at the proximal opening into the flow region is in a range between 20 microns to 500 microns.

6. The method of claim 1 , wherein a ratio of a length L con of the connection region of each isolation chamber to a width W con of the respective connection region at the proximal opening into the flow region is at least 1.0.

7. The method of claim 1 , wherein a height H ch of the flow region at the proximal opening of the respective connection region of each isolation chamber is in a range between 20 microns to 100 microns.

8. The method of claim 1 , further comprising, prior to freezing the microfluidic device, creating an inventory including at least an identity and isolation region location for each of the one or more sequestered biological cells, and storing the inventory in a memory associated with the microfluidic device.

9. The method of claim 8 , wherein the inventory further includes information identifying one or more of (i) how the biological cells in the flowable medium were obtained, (ii) processing, if any, performed on the biological cells prior to or after their introduction into the microfluidic device, (iii) processing, if any, performed on the one or more sequestered biological cells after their sequester within the microfluidic device, and (iv) data obtained in the course of any such pre or post sequestration processing.

10. The method of claim 1 , wherein freezing the microfluidic device comprises an initial controlled cooling of the microfluidic device to a temperature of 0° C., followed by a subsequent cooling of the microfluidic device to a subzero temperature.

11. The method of claim 1 , further comprising, prior to freezing the microfluidic device, introducing a cell preservation reagent into the microfluidic device.

12. The method of claim 1 , further comprising, thawing the microfluidic device, and, after thawing the microfluidic device, culturing one or more viable cells in the microfluidic device to thereby generate additional cells therein.

13. The method of claim 12 , the one or more sequestered biological cells comprising at least one or more starting cells sequestered in a first isolation region, the method further comprising:

prior to freezing the microfluidic device, culturing the one or more starting cells to generate a plurality of new cells in the first isolation region, the plurality of new cells being adequate in number so that at least one viable cell is located in the first isolation region after thawing the microfluidic device.

14. The method of claim 1 , further comprising performing an assay of the one or more sequestered biological cells.

15. The method of claim 14 , wherein the assay is performed prior to freezing the microfluidic device containing the one or more sequestered biological cells.

16. The method of claim 1 , wherein, prior to freezing the microfluidic device containing the one or more sequestered biological cells, the flow region and the one or more isolation regions are treated with a blocking solution to prevent or reduce cell adhesion.

17. The method of claim 1 , wherein the microfluidic device further comprises an inner substrate surface that comprises a coating material.

18. The method of claim 17 , wherein the coating material comprises a polymer comprising alkylene ether moieties, saccharide moieties, or amino acid moieties.

19. The method of claim 1 , wherein the electrode activation substrate comprises a DEP configuration.

20. The method of claim 19 , wherein the DEP configuration is optically actuated.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Nov 30, 2023
From: PHENOMEX INC.; BIRD MERGERSUB CORPORATION
To: BRUKER CELLULAR ANALYSIS, INC.
Reel/Frame 065726/0624 →
CHANGE OF NAME Recorded Sep 20, 2023
From: BERKELEY LIGHTS, INC.
To: PHENOMEX INC.
Reel/Frame 064961/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2021
From: WHITE, MARK P.; CHAPMAN, KEVIN T.; MCFARLAND, ANDREW W.; HOBBS, ERIC D.; LOWE, RANDALL D., JR.
To: BERKELEY LIGHTS, INC.
Reel/Frame 056498/0191 →
Continuity (3)
Continuation 15136777 · Apr 22, 2016
Provisional Application 62151382 · Apr 22, 2015
Related Publication 20210368781A1 · Dec 2, 2021